Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
A Randomized Open Label Phase 2 Study of Denintuzumab mafodotin (SGN -CD19A)
Clinical Trial Grant
Duke Scholars
Principal Investigator
Matthew Stuart McKinney
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Seattle Genetics, Inc
Start Date
May 23, 2016
End Date
February 18, 2019
Awarded By
Seattle Genetics, Inc
Start Date
May 23, 2016
End Date
February 18, 2019
